KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Other Operating Expenses (2016 - 2026)

Cme has reported Other Operating Expenses over the past 18 years, most recently at $466.6 million for Q1 2026.

  • Quarterly Other Operating Expenses rose 5.73% to $466.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Mar 2026, up 5.05% year-over-year, with the annual reading at $2.0 billion for FY2025, 3.35% up from the prior year.
  • Other Operating Expenses was $466.6 million for Q1 2026 at Cme, down from $553.9 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $553.9 million in Q4 2025 and troughed at $407.7 million in Q3 2022.
  • The 5-year median for Other Operating Expenses is $444.7 million (2023), against an average of $458.4 million.
  • Biggest five-year swings in Other Operating Expenses: fell 7.75% in 2022 and later increased 8.97% in 2023.
  • Tracing CME's Other Operating Expenses over 5 years: stood at $489.5 million in 2022, then increased by 5.74% to $517.6 million in 2023, then decreased by 0.99% to $512.5 million in 2024, then grew by 8.08% to $553.9 million in 2025, then fell by 15.76% to $466.6 million in 2026.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $466.6 million, $553.9 million, and $467.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.